Managing insider risks necessitates a combination of technological measures such as advanced monitoring tools and multi-factor authentication, psychological steps like regular mental health checks, the fostering of an inclusive organisational culture, regular training on data security, clear legal frameworks, and timely security audits. Signpost Six advocates this balanced approach to strengthen organisations from within and mitigate insider threats.
Wall Street’s Leaders and Laggards of 2024
2024 was a mixed year for biopharma stocks, with the iShares Biotechnology ETF and SPDR S&P Biotech ETF experiencing small decreases. Federal Reserve decisions caused
